TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. The company has developed a proprietary stem cell technology, 'VesCell', that is currently being used by hospitals in Thailand and Singapore to treat patients with heart disease and peripheral artery disease.
View Top Employees from TheraVitae| Website | http://www.theravitae.com |
| Revenue | $602000 |
| Employees | View employees |
| Phone | (662) 664-4290 |
| Fax | (662) 664-4289 |
| Industry | Hospitals & Clinics, Healthcare |
| Competitors | Athersys, Capricor Therapeutics, Inc., Mesoblast Limited, Promethera Biosciences, ReNeuron Group Plc |
| SIC | SIC Code 804 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 62139 Companies, NAICS Code 621 Companies |
Looking for a particular TheraVitae employee's phone or email?
TheraVitae Questions
The TheraVitae annual revenue was $602000 in 2024.
TheraVitae is based in Bangkok, Bangkok.
The NAICS codes for TheraVitae are [62, 6213, 621399, 62139, 621].
The SIC codes for TheraVitae are [804, 80].
